Swedish Orphan Biovitrum AB - Company Profile

Powered by

All the sales intelligence you need on Swedish Orphan Biovitrum AB in one solution.

$395 $295
Register your interest Learn more
  • Save hours of research time with a comprehensive
    Sales Intelligence Solution.

  • Understand how Swedish Orphan Biovitrum AB fits into your total
    addressable market and Ideal Customer Profile.

  • Gain competitive edge with triggers that tell you
    when and how to engage with Swedish Orphan Biovitrum AB.

Back to companies

Swedish Orphan Biovitrum AB: Deals

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Select Item

Related keylists

View up-to-date information on Swedish Orphan Biovitrum AB’s latest deals, number of deals and deal values, alongside insights into its key mergers and acquisitions.

Number of Deals

image for loader

Deal Value ($M)

Image for Loader
Gain insight into company strategy with premium access to M&A activity Gain insight into company strategy with premium access to M&A activity Learn more

Latest Deals

Announced Date Headline Deal Type Acquirers/Investors/Surviving Entity Issuer/Partner/Target
13 Sep 2023 DalCor Pharma Raises USD80 Million in Series D Financing Venture Financing
Andes Capital Group, LLC  

Fonds de solidarite FTQ  

Investissement Quebec Inc  

CTI Life Sciences Ltd  

TB Biosciences, Inc.  

DalCor Pharmaceuticals Inc  

18 Jul 2023 Swedish Orphan Biovitrum (Sobi) Raises USD0.03 Million in Rights Offering of Shares Equity Offering
Swedbank Robur Fonder AB  

Polar Capital Holdings Plc  

Investor AB
Fjarde AP fonden  

Handelsbanken Fonder AB  

Swedish Orphan Biovitrum AB
10 May 2023 Cleopatra Acquisition Acquires CTI BioPharma Acquisition
Cleopatra Acquisition Corp  

CTI BioPharma Corp
06 Apr 2021 Lorem ipsum dolor sit amet, consectetur adipiscing elit Eiusmod Tempor Exercitation cillum velit Exercitation cillum velit Tempor
06 Apr 2021 Lorem ipsum dolor sit amet, consectetur adipiscing elit Eiusmod Tempor Exercitation cillum velit Exercitation cillum velit Tempor
06 Apr 2021 Lorem ipsum dolor sit amet, consectetur adipiscing elit Eiusmod Tempor Exercitation cillum velit Exercitation cillum velit Tempor
Explore the latest deals, partnerships, mergers & acquisitions when you unlock full profile Explore the latest deals, partnerships, mergers & acquisitions when you unlock full profile Learn more
Get in touch about GlobalData Explorer

Contact the team or request a demo to find out how our data can drive your business forward

Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer